Reuters logo
BRIEF-Meridian Bioscience says sees FY 2016 earnings per share $0.75 to $0.76
October 18, 2016 / 8:55 PM / a year ago

BRIEF-Meridian Bioscience says sees FY 2016 earnings per share $0.75 to $0.76

Oct 18 (Reuters) - Meridian Bioscience Inc

* Comments on preliminary fiscal 2016 operating results and provides fiscal 2017 revenue and earnings guidance

* Sees FY 2017 earnings per share $0.81 to $0.85 excluding items

* Sees FY 2016 earnings per share $0.75 to $0.76

* Sees FY 2017 revenue $205 million to $210 million

* Sees FY 2017 revenue up 5 to 7 percent

* Sees FY 2016 revenue about $196 million

* Q4 revenue $47 million versus I/B/E/S view $49.2 million

* Continue to seek acquisition and collaboration opportunities to expand and extend core capabilities

* FY2016 earnings per share view $0.86, revenue view $198.5 million -- Thomson Reuters I/B/E/S

* FY2017 earnings per share view $0.91, revenue view $210.6 million -- Thomson Reuters I/B/E/S

* Magellan expected to be a penny dilutive to earnings per share for six months since acquisition, also better than expected Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below